What factors did the committee consider when determining that coronary revascularization should not be routinely offered to people with heart failure and reduced ejection fraction?
The committee considered the evidence based on a single trial, the characteristics of the patients in the trial compared to the UK population, the relatively small proportion of patients in the trial with Implantable Cardioverter Defibrillators (ICDs), and any possible benefit of coronary revascularization being outweighed by an increased risk of serious adverse events during or post-surgery.